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Background: In survival analysis, patients on peritoneal dialysis are confronted with three different outcomes:
transfer to hemodialysis, renal transplantation, or death. The Kaplan-Meier method takes into account one event
only, so whether it adequately considers these different risks is questionable. The more recent competing risks
method has been shown to be more appropriate in analyzing such situations.
Methods: We compared the estimations obtained by the Kaplan-Meier method and the competing risks method
(namely the Kalbfleisch and Prentice approach), in 383 consecutive incident peritoneal dialysis patients. By means of
simulations, we then compared the Kaplan-Meier estimations obtained in two virtual centers where patients had
exactly the same probability of death. The only difference between these two virtual centers was whether renal
transplantation was available or not.
Results: At five years, 107 (27.9%) patients had died, 109 (28.4%) had been transferred to hemodialysis, 91 (23.8%) had
been transplanted, and 37 (9.7%) were still alive on peritoneal dialysis; before five years, 39 (10.2%) patients were
censored alive on peritoneal dialysis. The five-year probabilities estimated by the Kaplan-Meier and the competing risks
methods were respectively: death: 50% versus 30%; transfer to hemodialysis: 59% versus 32%; renal transplantation: 39%
versus 26%; event-free survival: 12% versus 12%. The sum of the Kaplan-Meier estimations exceeded 100%, implying that
patients could experience more than one event, death and transplantation for example, which is impossible. In the
simulations, the probability of death estimated by the Kaplan-Meier method increased as the probability of renal
transplantation increased, although the probability of death actually remained constant.
Conclusion: The competing risks method appears more appropriate than the Kaplan-Meier method for estimating the
probability of events in peritoneal dialysis in the context of univariable survival analysis.Background
Patients with stage 5 chronic kidney disease (CKD) can
be treated by peritoneal dialysis (PD), hemodialysis (HD)
or renal transplantation. The efficacy of PD is frequently
assessed from the patient survival, estimated by the
Kaplan-Meier method and compared to patient survival
on HD using the Cox proportional-hazards model [1,2].
In these survival analyses, patients on PD may encounter
three outcomes: transfer to HD, renal transplantation, or
death. The Kaplan-Meier method can only take into* Correspondence: jean-baptiste.beuscart@univ-lille2.fr
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reproduction in any medium, provided the oraccount one of these events. The validity of the estima-
tions made using this approach for patients on PD is
therefore questionable.
A competing risk is an event which either hinders the
observation of the event of interest, or modifies its prob-
ability of occurrence [3,4]. In the survival analysis of PD
patients, renal transplantation or transfer to HD may
hinder the observation of death [1,2,5]. Transplantation
or transfer to HD should therefore be considered as
competing risks, which may influence the calculations
and therefore the results of the survival analysis [6].
Analysis of time-to-event data when competing risks
are present requires specific methods because standard
approaches can lead to estimation and interpretationl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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as cancer research and cardiology, or even in renal trans-
plantation, the Kaplan-Meier method has been shown to
overestimate the probability of death in comparison with
the more specific competing risks method [8-11].
The purpose of the present study was to assess the valid-
ity of the survival estimations in PD obtained by the
Kaplan-Meier method compared to the competing risks
method developed by Kalbfleisch and Prentice in a cohort
of 383 PD patients. The Kaplan-Meier method is often con-
sidered to estimate the survival that would be observed in
the absence of transfer to HD or transplantation. We used
simulations to investigate this assumption, and also tested
the competing risks approach under the same conditions.
Methods
Patients
This study was performed at the Lille University Medical
Center Nephrology Department (France). All consecu-
tive incident patients starting PD treatment between
January 1, 1992, and July 1, 2007 were included in the
study. The cut-off date was January 1, 2008. Data on age,
gender, diabetic status and primary renal diagnoses were
collected at baseline. The primary renal diagnosis was
classified according to the French renal epidemiology
and information network [12]. Follow-up ended in the
event of death, transfer to HD or renal transplantation,
transfer to another center, recovery of renal function, or
at termination of the study. The study was approved by
the Ethics Committee for Medical Research of the uni-
versity hospital of Lille (Correspondant Informatique et
Liberté, number 701012-GD).
Statistical methods
The current paper only focuses on univariate methods
for survival analysis. Two approaches can be used in the
survival analysis of PD patients. In the intention-to-treat
approach, death is taken into account if it occurs during
PD or after transfer to HD [1,2]. In this approach, renal
transplantation is a competing risk. In the as-treated ap-
proach, death is only taken into account if it occurs dur-
ing PD. In this approach, both transplantation and
transfer to HD are competing risks [5]. The analyses of
real data were performed according to an as-treated ap-
proach, in order to illustrate the three different events
that could occur in PD patients: death, transfer to HD,
or renal transplantation.
Estimation of event-free survival and cumulative incidences
Event-free survival is the probability of being free from
any event, which corresponds here to the probability of
staying alive on PD. All events are taken into account in
this survival estimation, so that there is no competition
between events. It can be assessed by the Kaplan-Meiermethod [4,7]. The events analyzed in the study were
death, transfer to HD, and renal transplantation. Alive at
cut-off date, transfer to another center, and recovery of
renal function were censored.
The cumulative incidence function of cause k is
defined by the probability of failing from cause k before
time t [3,7]. The cumulative incidence function was esti-
mated by both the Kaplan-Meier and the competing
risks methods for the following causes: death during PD,
transfer to HD, renal transplantation. With the Kaplan-
Meier method, only the event of interest was taken into
account and all other events were censored at the time
of the event. For example, to estimate the cumulative in-
cidence of death during PD, the following events were
censored: transfer to HD and renal transplantation. With
the competing risks method, death during PD, transfer
to HD, and renal transplantation were considered as
competing risks. The cumulative incidence function was
estimated for each of these outcomes using the approach
of Kalbfleisch and Prentice, which takes into account all
events in the calculations made through event-free sur-
vival [4]. As recommended, the duration shown on the
curves (figures are shown below) was stopped if less
than 10% of the patients were still under follow-up [13].
We conducted a sensitivity analysis by separating the co-
hort into two subgroups according to the date of inclu-
sion: early inclusion between 1992 and 1999, and late
inclusion between 2000 and 2007.Sum of probabilities
Death, transfer to HD, or renal transplantation were the
only three events that could occur in a given patient. In
their absence, patients were still alive on PD. By definition,
these four states are mutually exclusive: a patient cannot
simultaneously die and be transferred to HD, or be alive
on PD and have a renal transplant. Therefore, at all time
points, the sum of these probabilities must be equal to one.Simulations with or without the availability of renal
transplantation
The aim was to compare the survival estimates obtained
for two identical cohorts, one with the presence and the
other with the absence of competing risks. Such real data
are not available for dialysis, because randomized con-
trolled trials comparing dialysis alone to dialysis plus
transplantation have never been carried out for ethical rea-
sons. We therefore simulated two different situations in
two virtual centers. To simulate an intention-to-treat ana-
lysis, which is the preferred approach in the survival ana-
lysis of patients on PD, two events only were taken into
account: death or renal transplantation. The simulation
was based on specific characteristics (age and the presence
or not of diabetes) of the 383 patients in our cohort.
Table 1 Baseline characteristics of the 383 patients
included in the study
Patient characteristics Patients (n = 383)








High blood pressure 16 (4.2%)
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able. We used a Cox-Gompertz model to simulate the
survival time for each patient [14]. The parameters of
the model were calculated to closely simulate data from
Japan, where the renal transplantation rate is low [15].
We set a similar hazard ratio (HR) for death to that
obtained for our cohort using a Cox model: HR= 2 for
diabetes, HR= 3 for age between 60 and 75 years, HR= 9
for age over 75 years.
In virtual center 2, patients had the same survival
times as in center 1, the difference being that renal
transplantation was available. It has been reported that
patients on the waiting list have a higher survival time
than other patients [16], while age and the presence of
diabetes have been shown to influence access to renal
transplantation [17,18]. Therefore, for each patient i, the
probability pi of being placed on the waiting list decreased
with older age, the presence of diabetes, and lower sur-
vival time. Registration status (on the waiting list or not)
was then generated for each patient i using a Bernoulli
distribution for parameter pi. For patients on the waiting
list, waiting times were simulated with a Gompertz model.
All parameters were set to closely simulate registration on
the waiting list and waiting times in France [19]. If the
waiting time was shorter than the survival time, renal
transplantation was observed. If the waiting time was
longer than the survival time, or if the patient was not on
the waiting list, death was observed with the same survival
time as in that in center 1.
We compared the Kaplan-Meier estimations made for
the two virtual centers with the Log rank test. To avoid
a biased conclusion reached on the basis of a single
simulation, the latter was repeated 100 times and the
results were averaged. Six different simulations (repeated
100 times) were carried out to obtain six different pro-
portions of patients on the waiting list in center 2: 5, 10,
20, 30, 40, and 50% of the population on dialysis. Lastly,
we used the Kalbfleisch and Prentice method to estimate
the cumulative incidences of death and renal transplant-
ation in the two virtual centers.
Software
All statistical calculations were carried out using R soft-
ware (R Development Core Team [2009], R: A language
and environment for statistical computing) with the
“Survival” and “Cmprsk” packages.
Results
Patients and observed outcomes
Three hundred and eighty-three consecutive incident
patients were included in the study. Patient characteris-
tics were presented in Table 1. At five years, 107 patients
(27.9%) had died during PD treatment, 109 (28.4%) had
been transferred to HD, 91 (23.8%) had undergone renaltransplantation, and 37 (9.7%) were still on PD. The
other 39 (10.2%) patients had a shorter duration of fol-
low-up, and their data had been censored when they
were still alive on PD (33 patients), upon transfer to an-
other center (three patients), or after recovery of renal
function (three patients). The median follow-up period
was 15.7 months (interquartile range: 8.6–24.7).
Event-free survival and cumulative incidence estimations
Death was taken into account during PD only, in terms
of as-treated analysis. Event-free survival, which corre-
sponds to the probability of staying alive on PD, was
estimated at 12% at five years, as shown in Figure 1A.
The probability of remaining alive on PD decreased rap-
idly due to the high rate of events, evenly distributed be-
tween death, transfer to HD, and renal transplantation.
Cumulative incidence curves for each event estimated
by the Kaplan-Meier and Kalbfleisch and Prentice meth-
ods are shown in Figure 1B–D. With the Kaplan-Meier
method, the cumulative incidence estimations for death
during PD, transfer to HD, and renal transplantation
were systematically higher than the observed proportion
of events: 50% vs 27.9%, 59% vs 28.4%, and 39% vs
23.8%, respectively. Conversely, with the competing risks
method, at five years, the cumulative incidence estima-
tions for death during PD, transfer to HD and renal
transplantation amounted to 30%, 32% and 26% respect-
ively. This finding was in accordance with the observed
proportion of events, taking into account censored
observations.
With the Kaplan-Meier method, the 109 patients
transferred to HD and the 91 renal transplantations were
censored to estimate the probability of death during PD.
These 200 patients (51.6%) were considered to have the
same risk of dying during PD as those patients still on
Figure 1 A: Event-free survival, which corresponds to the probability of staying alive on peritoneal dialysis (PD). B-D: Cumulative
incidence estimations obtained by the Kaplan-Meier (KM) and the competing risks (CR) methods for: between death, transfer to HD, and renal
transplantation).
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mulative incidence of death between the Kaplan-Meier
method and the competing risks method, which
amounted to 20% at five years. The sensitivity analysis
showed that the results were similar for death and trans-
fer to HD between the early- and late-inclusion patients
(data not shown).
The sums of the reported probabilities at time t, esti-
mated using both methods, are shown in Figure 2. With
the Kaplan-Meier method, this sum rapidly exceeded
one. At five years, it amounted to 160%: 12% of patients
would be still alive on PD, 50% would have died, 59%
would have been transferred to HD, and 39% would have
been transplanted. This meant an expected number of
events per patient that was greater than one at five
years, which is not possible. In contrast, the sumof probabilities using the competing risks method
amounted to one at all times.
Simulations
Simulations were used to compare the survival estima-
tions obtained for two identical cohorts in different
competing risks settings. We simulated two virtual cen-
ters where patients had exactly the same characteristics
and the same probability of death. The only difference
between these two virtual centers was whether renal
transplantation was available (center 2) or not (center 1).
Death was taken into account on both PD and HD,
according to an intention-to-treat analysis. One hundred
simulations were carried out, and the results were aver-
aged. In virtual center 1, where renal transplantation
was not available, the median survival time was
Figure 2 Sum of probabilities estimated by the Kaplan-Meier and competing risks methods. Event-free survival (EFS) and the cumulative
incidence curves for death, transfer to hemodialysis (HD), and renal transplantation (RT) are stacked. The upper line (in bold) represents the sum
of probabilities of the different events.
Figure 3 Cumulative incidence of death for two simulated
dialysis populations with exactly the same probability of death,
obtained by the Kaplan-Meier method. The only difference
between the two virtual centers is whether renal transplantation (RT)
is available (center 2) or not (center 1).
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patients on the waiting list was 145 (38%) ± 7 patients.
The median waiting time before transplantation was
estimated at 2.5 ± 0.2 years.
The cumulative incidence of death estimated by the
Kaplan-Meier method is shown in Figure 3. The prob-
ability of death was exactly the same in the two virtual
centers but the estimated cumulative incidence of death
was significantly higher in virtual center 2, where trans-
plantation was available (P< 0.001 for each simulation).
In the latter center, 131 patients underwent renal trans-
plantation during the first 10 years. These observations
were censored at the time of transplantation. In virtual
center 1, the 131 corresponding patients were long-term
survivors, as 105 of them remained on dialysis for more
than five years, and 60 of them for more than 10 years.
The influence of censoring renal transplantation in the
Kaplan-Meier estimations increased with the proportion
of patients on the waiting list. The gap between the two
cumulative incidence curves increased from 1.5% to 18%
at ten years, when the proportion of patients on the
waiting list had increased from 5% to 50% (data not
shown).
With the competing risks method, the cumulative inci-
dence of death was systematically lower in virtual center
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transplantation, patients in virtual center 2 were no
longer considered at risk of death during dialysis. If the
curves had been continued until the last death event, the
cumulative incidence of death would have reached 100%
in virtual center 1 and 65% in virtual center 2, the 35%
difference between the two centers corresponding to the
transplanted patients.
Discussion
In our study, the Kaplan-Meier method overestimated
the probability of each event, i.e. death, transfer to HD,
or renal transplantation during PD. This approach takes
only one event into account, the other events being cen-
sored [3,4]. When the event investigated was death,
patients censored because of transfer to HD or renal
transplantation were considered to be withdrawn alive
on PD, which led to an overestimation of the probability
of death during PD. When the event studied was trans-
fer to HD or renal transplantation, patients who died
were censored and considered to be withdrawn alive on
PD. The sum of probabilities thus exceeded one, imply-
ing that more than one event could occur in a given pa-
tient. This is not possible in real terms, as for example a
patient cannot first die during PD then later have a renal
transplantation.
The competing risks method provided accurate esti-
mations of event probabilities when applied to our
study cohort. In particular, the sum of the estimatedFigure 4 Cumulative incidence of death and renal transplantation for
probability of death, obtained by the competing risks method. The on
transplantation (RT) is available (center 2) or not (center 1). Dashed verticalprobabilities amounted to one at all times. Our results
showed that in the PD setting, crude cumulative inci-
dences of each event could be estimated by means of the
Kalbfleisch and Prentice method. Using this approach,
patients who experienced an event were no longer at
risk of death during PD. Consequently, cumulative inci-
dence curves should not be interpreted alone [4,7]. For
instance, the interpretation of the cumulative incidence
of death must take into account the cumulative inci-
dence of renal transplantation and transfer to HD.
The Kaplan-Meier method is frequently considered to
estimate the virtual survival rate in PD, i.e. that which
would be observed in the absence of any competing risk.
However, the results of our simulations were not con-
sistent with this assumption. The probability of death
estimated when renal transplantation was censored (cen-
ter 2) was systematically higher than that estimated
when renal transplantation was not available (center 1).
This was due to the independence assumption under-
lying the censoring process, which assumes that indivi-
duals censored at time t have the same probability of
developing the event of interest beyond time t as those
who remain in follow-up [4,7,20]. Patients excluded be-
cause of renal transplantation were thus assumed to
have the same risk of death as patients still in follow-up.
This assumption does not hold true for dialysis: patients
on the waiting list are younger, healthier, and have a bet-
ter chance of survival than other patients [16-18]. These
results revealed a second problem when dealing with thetwo simulated dialysis populations with exactly the same
ly difference between the two virtual centers is whether renal
lines show the estimates at 2, 5, and 10 years for each center.
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patients remaining in the study changes when the
patients who are relatively healthy undergo renal trans-
plantation, leaving those with a worse prognosis on
dialysis.
The use of the competing risks method is recom-
mended in clinical settings where dependent events are
present [3,4,7]. However, the method of Kalbfleisch and
Prentice is also unable to estimate the virtual survival
rate in PD. In our simulations, the probability of death
estimated by this method was indeed lower when renal
transplantation was available (center 2) than when it was
not (center 1). The estimations of cumulative incidence
of death made by the Kalbfleisch and Prentice method
in virtual center 2 were correct, but they cannot be
interpreted alone. In fact, the lower incidence of death
observed in Figure 4 in center 2 was the consequence of
a high incidence of renal transplantation in this virtual
center. Transplantation has been shown to offer a sur-
vival advantage compared to dialysis, and the lower
probability of death on dialysis might be considered a
successful outcome [16,21]. Taken as a whole, these
results suggest that the competing risks method should
become the method of choice in PD survival analysis.
The use of competing risks methods may also be consid-
ered in nephrology in general, as the problem of com-
peting risks occurs frequently in many other groups of
patients. For example, the competing risk of renal trans-
plantation is also a factor to be taken into consideration
when analyzing survival of HD patients, or the compet-
ing risk of dialysis initiation when analyzing survival of
patients with chronic kidney disease, or the competing
risk of death with a functioning transplant when analyz-
ing the allograft survival in transplanted patients.
The efficacy of PD is frequently assessed on the basis
of patient survival and technical survival, estimated by
the Kaplan-Meier method. The transplantation rate var-
ies greatly between countries or centers [17,22]. As
shown in our study, centers with a high transplantation
rate may be penalized if their results for dialysis are
represented by these estimations. To compare PD cen-
ters, it would be useful to estimate the survival observed
in the absence of transfer to HD and renal transplant-
ation. To estimate this survival in a dependent, compet-
ing risks setting such as PD, fairly strong assumptions
have to be made and more sophisticated methods are
required [23,24]. The Kaplan-Meier method cannot
achieve this, and should only be used to estimate event-
free survival [4,7].
We applied the Kaplan-Meier and the competing risks
methods to a single-center cohort of 383 consecutive in-
cident patients, as recommended in the literature
[25,26]. Since nearly all events were observed over a 16-
year period of follow-up, with only 10.2% observationsbeing censored before five years, these results could be
considered reliable. The observed proportion of deaths,
transfer to HD, and transplantations was similar to that
reported for other European cohorts of incident PD
patients, making our cohort a valid basis for comparison
[27-29]. We used as-treated analysis to process our
observed data, and intention-to-treat analysis for our
simulations. In the literature, both approaches may be
used depending on the aim of the study [1,2,5].
Randomized controlled trials comparing dialysis alone
to dialysis plus transplantation are viewed as unethical,
and so have never been carried out. Data on patients for
whom access to transplantation would constitute the
only difference are therefore not available. Our response
to this situation was to make use of simulations. We
used a Gompertz model, which appears to be more ap-
propriate than the exponential or Weibull models [14],
and allowed us to make simulations based on real data.
However, a simulation cannot provide real observed
data, an aspect which should be kept in mind at the time
of interpretation. A case in point is that the exact form
of the dependence function between survival and regis-
tration for transplantation is unknown. Expert elicitation
would be useful in this regard, as for instance in envir-
onmental health where the knowledge-base is limited by
incomplete data [30].
As the aim of our study was to compare the two meth-
ods in general, and in particular to analyze the influence
of competing risks on Kaplan-Meier estimates, the ques-
tion of bivariate and multivariate analysis in a competing
risks setting was not addressed here.Conclusion
Our study has shown that the Kaplan-Meier method
overestimated the probability of death in the competing
risks setting of PD. The use of the competing risks
method is recommended in survival analysis when sev-
eral dependent events are possible. This approach is
used in other fields of medicine, such as hematology
[31,32]. It has also occasionally been used in nephrology,
renal transplantation, and in studying peritonitis-free
survival in PD [6,11,33]. We suggest that the competing
risks method should be adopted as the preferred ap-
proach in PD univariable survival analysis.
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